Triple A Polyclonals are highly characterized antibodies with all characterization data for each target protein publically accessible through the Human Protein Atlas (HPA) portal (proteinatlas.org). The uniqueness and low cross reactivity of the Triple A Polyclonals originate from a thorough selection of antigen regions, affinity purification of the polyclonal antibodies, validation using several methods and a stringent selection of approved antibodies. Read more about Triple A development and validation at the link below.
Read Article